Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...
The global continuous positive airway pressure (CPAP) market is projected to reach a value of USD 900 million by 2033, ...
Researchers, including experts from the University of Missouri School of Medicine, explored the use of senolytics—drugs ...
The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...
On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
Sundayjn to highlight the potential of Bubble Continuous Positive Airway Pressure (bCPAP), a locally manufactured, low-cost ...
OSA impacts about 936 million people worldwide and occurs when the throat muscles relax and block the airway with a common ...
ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians: Our Bureau, Bengaluru Monday, January 6, 2025, 17:30 Hrs [IST] ResMed, the world’s leading he ...